Olivier Gires is a full professor at the ENT research department, Munich Medical Center, Germany. In 1999, he obtained his PhD in biology for his work on Epstein-Barr virus' oncoprotein LMP1. Thereafter, Olivier Gires focused on the identification and molecular characterization of tumor-associated antigens with particular emphasis on the elucidation of the function of the therapeutic target EpCAM. Work by his group unraveled the oncogenic potential of EpCAM along with underlying molecular mechanisms of EpCAM signalling. Presently, Prof. Gires´ work concentrates on the characterisation of markers of cancer stem cells such as EpCAM and CD133 in head and neck squamous cell carcinomas and in murine embryonic stem cells.
Biography Updated on 16 April 2013